The average length of stay for malignant neoplasm of the uterus in Germany is forecasted to decrease from 8.2 days in 2024 to 7.8 days by 2028. This trend reflects a gradual reduction in hospital stay durations as medical advancements and efficiencies continue to improve treatment and recovery times.
From 2024 to 2025, there is a decline of approximately 1.22%, followed by a 1.23% reduction from 2025 to 2026, and a sharper decline of 2.5% from 2026 to 2027. The duration remains stable in 2027 and 2028, with no further decrease observed.
Overall, the compound annual growth rate (CAGR) indicates an average decline in length of stay of about 1.25% per year over the five years from 2024 to 2028.
Future trends to monitor include innovations in surgical techniques and post-operative care, as well as advances in early detection and alternative treatments, which could further reduce hospital stay durations. Additionally, healthcare policy changes and resource allocation could impact these forecasts.
